Sponsor Deadline
Posted: 4/18/2022

Emerging Therapies for Atopic Dermatitis and Alopecia Areata for Advanced Practice Providers

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

The landscape of treatment for inflammatory skin conditions, including Atopic Dermatitis and Alopecia Areata, is advancing, with more evidence and therapeutic options available to the community, including JAK inhibitors.

Through this RFP, it is our intent to support educational projects that focus on addressing knowledge and practice gaps specific to the recognition, diagnosis, treatment, and overall care management of Atopic Dermatitis (AD) and Alopecia Areata (AA). Projects that will be considered for Pfizer support should focus on increasing the knowledge and understanding of:

1) the pathophysiology of AA and AD with specific focus on immunologic pathways

2) the epidemiology of the disease(s), including an understanding of the risk factors for the development of the disease(s), comorbidities, and safety events relevant to systemic therapies

3) understanding the clinical manifestation of AD/AA, including a holistic review of the burden of disease (e.g.: psychosocial burden and associated autoimmune and atopic disorders)

4) new advances in the treatment pathways of AA and AD

5) mechanism of action of treatments in AA and AD

6) the benefit/risk profile of systemic treatments for AA and AD treatments (e.g.: JAK inhibitors)

Grant Application due date: November 16, 2021

Eligibility Requirements

Geographic Scope: United States

• The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. all institutions must have a relevant role and the requesting organization must have a key role in the project. • For projects offering continuing education credit, the requesting organization must be accredited.

Amount Description

Individual projects requesting up to $250,000 will be considered.

Funding Type